US 11,903,958 B2
Therapeutic agents and methods of producing same
Alan David Payne, Fremantle (AU); Bruno Basic, Kriftel (DE); Shifaza Mohamed, Victoria Park (AU); and Deirdre Roma Coombe, Wembly Downs (AU)
Assigned to GLYCOSYNNOVATIONS PTY LTD, Cloverdale (AU)
Appl. No. 16/341,777
Filed by GLYCOSYNNOVATIONS PTY LTD, Cloverdale (AU)
PCT Filed Oct. 12, 2017, PCT No. PCT/AU2017/051102
§ 371(c)(1), (2) Date Apr. 12, 2019,
PCT Pub. No. WO2018/068090, PCT Pub. Date Apr. 19, 2018.
Claims priority of provisional application 62/407,109, filed on Oct. 12, 2016.
Prior Publication US 2021/0386770 A1, Dec. 16, 2021
Int. Cl. A61K 31/7056 (2006.01); A61K 47/54 (2017.01); A61P 29/00 (2006.01); A61K 31/7034 (2006.01); C07H 19/056 (2006.01); C07H 15/00 (2006.01); C07H 15/26 (2006.01)
CPC A61K 31/7056 (2013.01) [A61K 31/7034 (2013.01); A61K 47/545 (2017.08); A61P 29/00 (2018.01); C07H 15/00 (2013.01); C07H 15/26 (2013.01); C07H 19/056 (2013.01)] 13 Claims
OG exemplary drawing
 
1. A compound selected from the group consisting of:

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry